Efficacy News and Research

RSS

Phase II open-label study demonstrates that high-risk populations adhere well to daily regimen of PrEP

Results from HPTN 067, a Phase II, randomized, open-label study, demonstrate most study participants had higher coverage of sex events and better adherence when they were assigned to the daily dosing arm, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.

21 Jul 2015

TTP’s elastography imaging technology provides vital diagnostic information during surgery

The Technology Partnership plc, a leading UK-based research and product development company, has made major advances in the use of elastography, a medical imaging technique that maps the elastic properties of soft tissue to provide vital diagnostic information during surgery.

21 Jul 2015

Researchers successfully treat eczema patients using rheumatoid arthritis drug

Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The study is evidence of a potential new era in eczema treatment, they report.

21 Jul 2015

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.

20 Jul 2015

New study may help identify novel ways to treat immune thrombocytopenia

Immune thrombocytopenia, or ITP, is an autoimmune disease whereby the immune system sends antibodies to attack and destroy the body's platelets--blood cells responsible for controlling bleeding.

20 Jul 2015

Scientists find potent agent that thwarts drug resistance in malaria parasite

Scientists have made an important breakthrough in the fight against malaria, identifying a potent agent that thwarts drug resistance in the parasite that causes the disease.

20 Jul 2015

Natural supplement may improve quality of life for people who have celiac disease and gluten intolerance

University of Alberta researchers may have found a way to help people with celiac disease enjoy the wide variety of foods they normally have to shun.

17 Jul 2015

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential use of an existing chemotherapeutic cancer drug.

17 Jul 2015

New brain stimulation technique could improve physical performance

Researchers have discovered a new technique to enhance brain excitability that could improve physical performance in healthy individuals such as athletes and musicians.

17 Jul 2015

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

US-Australian drug discovery company, Novogen Limited, today announced that it has received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma.

16 Jul 2015

New drug DSM265 shows potential to cure, prevent malaria

Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.

16 Jul 2015

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, today announced the completion of an oversubscribed $40MM Series D financing round.

15 Jul 2015

Futura Medical develops new generation of topical pain relief

Futura Medical has developed a "new generation" of topical pain relief with two products that target more active ingredients directly to the point of pain. The new products have the potential to transform the pain relief market, according to chief executive James Barder.

15 Jul 2015

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) have been released by an international group of leading respiratory societies, The new guidelines, issued by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association, were published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

15 Jul 2015

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

An Indiana University Melvin and Bren Simon Cancer Center researcher played a role in the recent Food and Drug Administration approval of a drug to treat people exposed to potentially lethal doses of radiation.

15 Jul 2015

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Among patients with diabetic kidney disease and hyperkalemia (elevated potassium levels in the blood), a potentially life-threatening condition, those who received the new drug patiromer, twice daily for four weeks, had significant decreases in potassium levels which lasted through one year, according to a study in the July 14 issue of JAMA.

15 Jul 2015

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.

15 Jul 2015

USF College of Nursing awarded NCI grant to study mindfulness-based stress reduction in breast cancer survivors

The National Cancer Institute has awarded more than $2.8 million to University of South Florida College of Nursing to study memory and concentration among breast cancer survivors using a meditation-based stress reduction intervention.

15 Jul 2015

NAM report calls for strengthening psychosocial interventions for mental health, substance use disorders

A plan to ensure that evidence-based psychosocial interventions are routinely used in clinical practice and made a part of clinical training for mental health professionals was released today by the National Academy of Medicine.

15 Jul 2015

Benzodiazepine drugs ineffective for PTSD and trauma treatment

Benzodiazepine drugs are widely used in patients with posttraumatic stress disorder (PTSD), but available evidence suggests that they are not effective--and may even be harmful, concludes a systematic review and meta-analysis in the July Journal of Psychiatric Practice.

15 Jul 2015

Efficacy News and Research

Phase II open-label study demonstrates that high-risk populations adhere well to daily regimen of PrEP

TTP’s elastography imaging technology provides vital diagnostic information during surgery

Researchers successfully treat eczema patients using rheumatoid arthritis drug

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

New study may help identify novel ways to treat immune thrombocytopenia

Scientists find potent agent that thwarts drug resistance in malaria parasite

Natural supplement may improve quality of life for people who have celiac disease and gluten intolerance

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

New brain stimulation technique could improve physical performance

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

New drug DSM265 shows potential to cure, prevent malaria

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

Futura Medical develops new generation of topical pain relief

Updated guidelines released for treatment of idiopathic pulmonary fibrosis

IU researcher plays role in recent FDA approval of Neupogen drug to treat people exposed to radiation

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Agilent and BTI collaborate to address a critical need in biopharmaceutical industry

USF College of Nursing awarded NCI grant to study mindfulness-based stress reduction in breast cancer survivors

NAM report calls for strengthening psychosocial interventions for mental health, substance use disorders

Benzodiazepine drugs ineffective for PTSD and trauma treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News